What is the At-Home Drug of Abuse Testing market size?

The At-Home Drug of Abuse Testing market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the At-Home Drug of Abuse Testing market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the At-Home Drug of Abuse Testing market?

Key drivers include rising substance abuse cases and growing awareness about at-home testing convenience.

What are the challenges facing the At-Home Drug of Abuse Testing market?

Challenges include regulatory hurdles, product accuracy concerns, and competition from laboratory testing.

Which regions are leading the At-Home Drug of Abuse Testing market?

North America and Europe are regional leaders, driven by high demand and awareness.

Who are the top companies in the At-Home Drug of Abuse Testing market?

Top companies include Roche, Abbott, and Thermo Fisher, offering a range of testing products.

What future opportunities exist in the At-Home Drug of Abuse Testing market?

Future opportunities include emerging markets, technological advancements, and growing demand for rapid testing.

How is technology impacting the At-Home Drug of Abuse Testing market?

Technology is driving innovation, with advancements in rapid testing, digital health, and connected devices.

What is the current regulatory landscape for the At-Home Drug of Abuse Testing market?

The regulatory landscape is evolving, with a focus on ensuring product safety, efficacy, and compliance.

What is the future outlook for the At-Home Drug of Abuse Testing market?

The future outlook is positive, with growing demand, advancing technology, and increasing awareness driving market growth.

At-Home Drug of Abuse Testing Market Growing at CAGR — 2026 Report

At-Home Drug of Abuse Testing by Type (Test Cups, Test Strips, Others), by Application (Online Sales, Offline Sales), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $8.7 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $8.7 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

At-Home Drug of Abuse Testing Market Overview

The At-Home Drug of Abuse Testing market refers to the industry that provides testing solutions for individuals to detect drug abuse from the comfort of their own homes. As the At-Home Drug of Abuse Testing market size is expected to reach $1.4 billion by 2026, the growth outlook and market forecast indicate a significant expansion of the industry, driven by increasing demand for convenient and discreet testing solutions. The At-Home Drug of Abuse Testing market is poised for substantial growth, with a compound annual growth rate (CAGR) of 8.5% during the forecast period, driven by macro drivers such as rising drug abuse rates, growing awareness about drug testing, and advancements in testing technologies.

Loading chart…

Key forces shaping the At-Home Drug of Abuse Testing industry include technology shifts, such as the development of more accurate and convenient testing kits, regulations, such as changing laws and policies regarding drug testing, and consumer behavior, such as increasing demand for discreet and affordable testing solutions. The largest region in the At-Home Drug of Abuse Testing market is North America, while the fastest-growing region is expected to be the Asia-Pacific region. As the industry continues to evolve, it is essential for market players to stay ahead of the curve by investing in research and development, expanding their product offerings, and building strong distribution networks to capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	8.70 million
Revenue forecast in 2033	18.92 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Dragerwerk; Assure Tech; Atas Medical GmbH; Confirm Biosciences; F. Hofmann-la Roche AG; Siemens Healthineers; Thermo Fisher Scientific; Bio-rad Laboratories; Psychemedics Corporation; Ora Sure Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The At-Home Drug of Abuse Testing market is poised for significant growth, driven by evolving demographics, technological advancements, and shifting regulatory landscapes. Understanding the market dynamics is crucial for stakeholders to navigate this complex and rapidly changing environment.

Growth Drivers2 items

Increasing awareness about substance abuse and the importance of early detection is driving the demand for At-Home Drug of Abuse Testing solutions, contributing to the growth forecast of the At-Home Drug of Abuse Testing market size.

Advancements in testing technologies, such as point-of-care devices and digital platforms, are enhancing the accuracy, convenience, and accessibility of At-Home Drug of Abuse Testing, further propelling the market's growth.

Restraints2 items

Stringent regulatory requirements and the need for compliance with various standards can act as barriers to entry for new players in the At-Home Drug of Abuse Testing market, potentially limiting market expansion.

Concerns over the accuracy and reliability of at-home tests, as well as issues related to privacy and data security, may hinder the adoption of At-Home Drug of Abuse Testing solutions among certain consumer segments.

Opportunities2 items

The growing trend towards personalized medicine and preventive care presents opportunities for the development of tailored At-Home Drug of Abuse Testing solutions that can cater to individual needs, thereby increasing the At-Home Drug of Abuse Testing market size.

Partnerships between manufacturers, healthcare providers, and digital health platforms can facilitate the integration of At-Home Drug of Abuse Testing into broader healthcare services, enhancing its accessibility and appeal to a wider audience.

Challenges2 items

The At-Home Drug of Abuse Testing market faces challenges related to the stigma associated with drug abuse, which can discourage individuals from seeking testing and treatment, thus affecting the growth forecast.

Ensuring the quality and efficacy of At-Home Drug of Abuse Testing products in a highly competitive market, where pricing pressure and varying regulatory standards can impact product development and distribution, is a significant challenge.

Market Segmentation

Loading chart…

The Type segment in the At-Home Drug of Abuse Testing market refers to the various types of tests available for detecting drug abuse. This includes tests for specific drugs such as marijuana, cocaine, and opioids, as well as multi-panel tests that can detect multiple substances at once. Understanding the different types of tests is crucial for At-Home Drug of Abuse Testing segmentation, as it helps to identify the most commonly used tests and areas of growth in the market.

The Application segment in the At-Home Drug of Abuse Testing market encompasses the various settings in which these tests are utilized. This includes personal use, employment screening, and law enforcement. Each application has its unique requirements and preferences, influencing the demand for specific types of tests. Analyzing the application segment is essential for understanding the market dynamics and identifying opportunities for growth in the At-Home Drug of Abuse Testing market.

At-Home Drug of Abuse Testing Segmentation Breakdown7 items

Type

Test Cups

Test Strips

Others

Application

Online Sales

Offline Sales

Regional Insights

Loading chart…

The At-Home Drug of Abuse Testing market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of at-home testing kits, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: North America - demographics with a high prevalence of drug abuse, ecosystem maturity with established players, and infrastructure with well-developed distribution channels; Europe - policies supporting at-home testing, adoption of innovative technologies, and investments in research and development; Asia Pacific - demographics with a large and growing population, infrastructure development, and ecosystem maturity with increasing awareness; Latin America - adoption of at-home testing kits, policies supporting healthcare access, and investments in healthcare infrastructure; Middle East & Africa - infrastructure development, ecosystem maturity, and policies supporting healthcare access.

The regional forecast indicates a significant growth opportunity in the At-Home Drug of Abuse Testing market, driven by increasing awareness, adoption of at-home testing kits, and favorable policies. As the market continues to evolve, it is essential to monitor regional trends and market growth to capitalize on emerging opportunities.

Competitive Landscape

The At-Home Drug of Abuse Testing market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The At-Home Drug of Abuse Testing competitive landscape is characterized by high competition, with companies focusing on differentiation through product portfolios and distribution channels.

Companies in the market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to stay competitive. Competitive differentiation is achieved through technology, service models, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players in the market include:

Abbott Laboratories: regional expansion

Dragerwerk: innovation pipeline

Assure Tech: OEM tie-ups

Atas Medical GmbH: local manufacturing

Confirm Biosciences: premium pricing

F. Hofmann-la Roche AG: vertical integration

Key At-Home Drug of Abuse Testing Companies11 items

Abbott Laboratories

Dragerwerk

Assure Tech

Atas Medical GmbH

Confirm Biosciences

F. Hofmann-la Roche AG

Siemens Healthineers

Thermo Fisher Scientific

Bio-rad Laboratories

Psychemedics Corporation

Ora Sure Technologies

Market Ecosystem

The At-Home Drug of Abuse Testing ecosystem encompasses a complex network of participants, spanning from upstream technology providers and suppliers to downstream end users. The ecosystem can be broadly categorized into three segments: upstream, midstream, and downstream. Upstream participants, such as technology providers and raw material suppliers, create essential components and technologies. Midstream participants, including OEMs and system integrators, assemble and integrate these components into final products. Downstream participants, comprising distributors, service providers, and end users, facilitate the delivery and utilization of these products, ultimately capturing value.

Raw material suppliers — providing chemical reagents

Technology providers — developing testing technologies

OEMs / manufacturers — producing testing devices

System integrators / EPCs — integrating testing systems

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering support and maintenance

Regulators/standards bodies — establishing testing standards

In the At-Home Drug of Abuse Testing ecosystem, value flows through the creation and capture of testing products and services. Control points, such as regulatory approvals and standards, influence the adoption of these products. Dependency risks, including input constraints and approvals, can impact the ecosystem's functioning. Furthermore, switching costs, partnerships, and interoperability requirements can affect the dynamics between participants. As the ecosystem differs by region, with varying regulatory frameworks and market demands, a thorough value chain analysis is necessary to understand the intricacies of the At-Home Drug of Abuse Testing ecosystem.

Recent Industry Insights

The At-Home Drug of Abuse Testing industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between diagnostic companies and healthcare providers, have expanded the reach of at-home testing kits. Notable mergers and acquisitions have also taken place, with major players acquiring smaller companies to enhance their product portfolios.

Additionally, there have been several product and technology launches, including innovative oral fluid testing devices and digital platforms for result reporting. Regulatory changes, such as updated guidelines for at-home testing, have also impacted the industry. Furthermore, a shift in consumer trends towards convenient and discreet testing options has driven demand for at-home testing kits, with companies responding by investing in funding rounds or expansions to meet this growing need.

Analyst Overview

As the Lead Analyst for this study, my expert view on the At-Home Drug of Abuse Testing market outlook is that it presents a moderately attractive opportunity, driven by growing concerns over substance abuse and the need for discreet, convenient testing solutions. The competitive intensity is relatively high, with several established players and new entrants vying for market share.

The long-term outlook for this market is positive, with increasing demand for at-home testing kits and innovative products that offer advanced features and accuracy. However, the demand-supply balance may be affected by factors such as regulatory changes and fluctuations in raw material costs. Key risk factors include intense competition, pricing pressure, and the need for continuous innovation to stay ahead in the market.

12 items

1. Executive Summary

2. At-Home Drug of Abuse Testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global At-Home Drug of Abuse Testing Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global At-Home Drug of Abuse Testing Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global At-Home Drug of Abuse Testing Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global At-Home Drug of Abuse Testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global At-Home Drug of Abuse Testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global At-Home Drug of Abuse Testing Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global At-Home Drug of Abuse Testing Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global At-Home Drug of Abuse Testing Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global At-Home Drug of Abuse Testing Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global At-Home Drug of Abuse Testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global At-Home Drug of Abuse Testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global At-Home Drug of Abuse Testing Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global At-Home Drug of Abuse Testing Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global At-Home Drug of Abuse Testing Market Competition by Key Manufacturers

9.1. Global At-Home Drug of Abuse Testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global At-Home Drug of Abuse Testing: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Abbott Laboratories

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Dragerwerk

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Assure Tech

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Atas Medical GmbH

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Confirm Biosciences

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. F. Hofmann-la Roche AG

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Siemens Healthineers

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Thermo Fisher Scientific

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Bio-rad Laboratories

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Psychemedics Corporation

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Ora Sure Technologies

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global At-Home Drug of Abuse Testing Market

Figure 4: Global At-Home Drug of Abuse Testing Market: Drivers

Figure 5: Global At-Home Drug of Abuse Testing Market: Challenges

Figure 6: Global At-Home Drug of Abuse Testing Market: Trends

Figure 7: Global At-Home Drug of Abuse Testing Market: Opportunity

Figure 8: Global At-Home Drug of Abuse Testing Market: Restraint

Figure 9: Global At-Home Drug of Abuse Testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global At-Home Drug of Abuse Testing Market Value (USD Million) By Region

Figure 19: Global At-Home Drug of Abuse Testing Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global At-Home Drug of Abuse Testing Market Value (USD Million) By Region

Figure 27: Global At-Home Drug of Abuse Testing Market Share (%) By: Regions (2032)

Figure 28: Global At-Home Drug of Abuse Testing Market Volume (K) By Region

Figure 29: Global At-Home Drug of Abuse Testing Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global At-Home Drug of Abuse Testing Market Value (USD Million) By Region

Figure 37: Global At-Home Drug of Abuse Testing Market Share (%) By: Regions (2032)

Figure 38: Global At-Home Drug of Abuse Testing Market Volume (K) By Region

Figure 39: Global At-Home Drug of Abuse Testing Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global At-Home Drug of Abuse Testing Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global At-Home Drug of Abuse Testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global At-Home Drug of Abuse Testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global At-Home Drug of Abuse Testing Market Value (USD Million) By Region

Table 14: Global At-Home Drug of Abuse Testing Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global At-Home Drug of Abuse Testing Market Volume (K) By Region

Table 31: Global At-Home Drug of Abuse Testing Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global At-Home Drug of Abuse Testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global At-Home Drug of Abuse Testing Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global At-Home Drug of Abuse Testing Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Abbott Laboratories Basic Information And Sales Area

Table 52: Abbott Laboratories. Products Portfolio

Table 53: Dragerwerk Basic Information And Sales Area

Table 54: Dragerwerk. Products Portfolio

Table 55: Assure Tech Basic Information And Sales Area

Table 56: Assure Tech. Products Portfolio

Table 57: Atas Medical GmbH Basic Information And Sales Area

Table 58: Atas Medical GmbH. Products Portfolio

Table 59: Confirm Biosciences Basic Information And Sales Area

Table 60: Confirm Biosciences. Products Portfolio

Table 61: F. Hofmann-la Roche AG Basic Information And Sales Area

Table 62: F. Hofmann-la Roche AG. Products Portfolio

Table 63: Siemens Healthineers Basic Information And Sales Area

Table 64: Siemens Healthineers. Products Portfolio

Table 65: Thermo Fisher Scientific Basic Information And Sales Area

Table 66: Thermo Fisher Scientific. Products Portfolio

Table 67: Bio-rad Laboratories Basic Information And Sales Area

Table 68: Bio-rad Laboratories. Products Portfolio

Table 69: Psychemedics Corporation Basic Information And Sales Area

Table 70: Psychemedics Corporation. Products Portfolio

Table 71: Ora Sure Technologies Basic Information And Sales Area

Table 72: Ora Sure Technologies. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Type

Table 74: Global Market Share (%) By Type (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Type

Table 78: Global Market Share (%) By Type (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global At-Home Drug of Abuse Testing Market Value (USD Million) By Region

Table 82: Global At-Home Drug of Abuse Testing Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Type

Table 85: North America Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Type

Table 88: Europe Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Type

Table 94: South America Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 98: Global At-Home Drug of Abuse Testing Market Volume (K) By Region

Table 99: Global At-Home Drug of Abuse Testing Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Type

Table 102: North America Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Type

Table 105: Europe Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Type

Table 111: South America Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

At-Home Drug of Abuse Testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.70 million
Revenue forecast in 2033	18.92 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Dragerwerk; Assure Tech; Atas Medical GmbH; Confirm Biosciences; F. Hofmann-la Roche AG; Siemens Healthineers; Thermo Fisher Scientific; Bio-rad Laboratories; Psychemedics Corporation; Ora Sure Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

At-Home Drug of Abuse Testing Segmentation Breakdown7 items

Type

Test Cups

Test Strips

Others

Application

Online Sales

Offline Sales

Regional Insights

Loading chart…

Competitive Landscape

Abbott Laboratories: regional expansion

Dragerwerk: innovation pipeline

Assure Tech: OEM tie-ups

Atas Medical GmbH: local manufacturing

Confirm Biosciences: premium pricing

F. Hofmann-la Roche AG: vertical integration

Key At-Home Drug of Abuse Testing Companies11 items

Abbott Laboratories

Dragerwerk

Assure Tech

Atas Medical GmbH

Confirm Biosciences

F. Hofmann-la Roche AG

Siemens Healthineers

Thermo Fisher Scientific

Bio-rad Laboratories

Psychemedics Corporation

Ora Sure Technologies

Market Ecosystem

Raw material suppliers — providing chemical reagents

Technology providers — developing testing technologies

OEMs / manufacturers — producing testing devices

System integrators / EPCs — integrating testing systems

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering support and maintenance

Regulators/standards bodies — establishing testing standards

Recent Industry Insights

Analyst Overview

Table of Contents